GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (SZSE:300534) » Definitions » Interest Coverage

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Interest Coverage : 39.60 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Gansu Longshenrongfa Pharmaceutical Industry Co Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Gansu Longshenrongfa Pharmaceutical Industry Co's Operating Income for the three months ended in Mar. 2024 was ¥36 Mil. Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Expense for the three months ended in Mar. 2024 was ¥-1 Mil. Gansu Longshenrongfa Pharmaceutical Industry Co's interest coverage for the quarter that ended in Mar. 2024 was 39.60. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage or its related term are showing as below:

SZSE:300534' s Interest Coverage Range Over the Past 10 Years
Min: 2.36   Med: 47.58   Max: 2140.77
Current: 24.78


SZSE:300534's Interest Coverage is ranked better than
60.59% of 675 companies
in the Drug Manufacturers industry
Industry Median: 12.98 vs SZSE:300534: 24.78

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Gansu Longshenrongfa Pharmaceutical Industry Co Interest Coverage Historical Data

The historical data trend for Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Gansu Longshenrongfa Pharmaceutical Industry Co Interest Coverage Chart

Gansu Longshenrongfa Pharmaceutical Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.80 2.36 - 2,140.77 25.67

Gansu Longshenrongfa Pharmaceutical Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.29 24.98 18.27 18.70 39.60

Competitive Comparison of Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage falls into.



Gansu Longshenrongfa Pharmaceutical Industry Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Expense was ¥-4 Mil. Its Operating Income was ¥101 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥113 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2023 )/Interest Expense (A: Dec. 2023 )
=-1*101.318/-3.947
=25.67

Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Here, for the three months ended in Mar. 2024, Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Expense was ¥-1 Mil. Its Operating Income was ¥36 Mil. And its Long-Term Debt & Capital Lease Obligation was ¥113 Mil.

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*35.992/-0.909
=39.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Gansu Longshenrongfa Pharmaceutical Industry Co  (SZSE:300534) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Gansu Longshenrongfa Pharmaceutical Industry Co Interest Coverage Related Terms

Thank you for viewing the detailed overview of Gansu Longshenrongfa Pharmaceutical Industry Co's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Business Description

Traded in Other Exchanges
N/A
Address
No. 10, Defence Road, Dingyuan Town, Gansu Province, Lanzhou, CHN, 730101
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is mainly engaged in the pharmaceutical business. It is engaged in the research and development of new drugs, traditional Chinese medicine processing and production. Its products portfolio includes Yuan Hu Zhitong Dripping Pills, Qiwei Wenyang Capsule and Xiaoshuan Tongluo Tablets. Its products are used to adjust gas, promote blood circulation, relieve pain, relieve cough, eliminate phlegm, relieve asthma, clear heat, and dispel dampness, among others.
Executives
Chen Yao Wu Executives
Zhang Jin De Director
Zhang Fan Executives
Kong Jian Feng Executives
Yue Qing Xin Supervisors
Kang Yong Hong Executives

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Headlines

No Headlines